This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Anne Hubbard
Introduction
Anne Hubbard is an accomplished inventor based in Terre Haute, IN (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic methods. Her work focuses on enhancing radiation therapy for cancerous tumors, utilizing advanced materials to improve treatment outcomes.
Latest Patents
Anne Hubbard holds a patent for her groundbreaking invention titled "Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis." This patent describes systems and methods for radiation therapy that employ biocompatible quantum dots. These quantum dots are designed to provide radiation dose enhancement and resistance to metastasis. The method involves preparing a radiosensitizer fluid containing a plurality of biocompatible quantum dots, introducing this fluid to cancer cells, and irradiating the cells to promote the generation of reactive oxygen species while inhibiting radiation-induced enhancement of cell migration.
Career Highlights
Anne Hubbard is affiliated with Creighton University, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes. With a focus on innovative solutions, she is dedicated to advancing the field of oncology.
Collaborations
Anne collaborates with notable colleagues, including Andrew Edet Ekpenyong and Caleb Thiegs. Their combined expertise contributes to the success of her research initiatives and the development of new therapeutic strategies.
Conclusion
Anne Hubbard's innovative work in cancer radiation therapy exemplifies the potential of biocompatible quantum dots in enhancing treatment efficacy. Her contributions are paving the way for more effective cancer therapies, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
